Acuson of Mountain View, CA, demonstrated a 64-channel intravascular ultrasound catheter as a work-in-progress for cardiac imaging at last month's American Heart Association meeting in Dallas. The company believes that the side-fire catheter should be
Acuson of Mountain View, CA, demonstrated a 64-channel intravascular ultrasound catheter as a work-in-progress for cardiac imaging at last month's American Heart Association meeting in Dallas. The company believes that the side-fire catheter should be more versatile than one-channel IVUS catheters.
The catheter is placed in the right atrium for intracardiac imaging and provides better image quality than a transthoracic or transesophageal probe, according to the company. It supports color Doppler, Doppler Tissue Imaging, spectral imaging, and almost all imaging techniques available on the Aspen or Sequoia scanners.
Acuson has an investigational device exemption for the transducer and is conducting clinical trials for the probe. The company plans to file a 510(k) application next year.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.